U.S. BioDefense Cordially Invited by Canadian Consulate to Attend the Internationalizing Early-Stage Clinical Drug Research & Development Conference
18 févr. 2005 07h00 HE
|
U.S. BioDefense
CITY OF INDUSTRY, Calif., Feb. 18, 2005 (PRIMEZONE) -- U.S. BioDefense, Inc. (OTCBB:UBDE) announces that they will be attending the Internationalizing Early-Stage Clinical Drug Research & Development...
U.S. BioDefense Retains Shannon Eaker, Ph.D. as a Consultant for Stem Cell Center of Excellence RFA Response
16 févr. 2005 09h30 HE
|
U.S. BioDefense
CITY OF INDUSTRY, Calif., Feb. 16, 2005 (PRIMEZONE) -- U.S. BioDefense, Inc. (OTCBB:UBDE) is pleased to announce today that the company has retained the consulting services of Shannon S. Eaker,...
U.S. BioDefense Plans Response for Funding and Building 'Center of Excellence in Stem Cell Research' a $4.5 Million National Institutes of Health RFA
11 févr. 2005 14h12 HE
|
U.S. BioDefense
CITY OF INDUSTRY, Calif., Feb. 11, 2005 (PRIMEZONE) -- U.S. BioDefense, Inc. (OTCBB:UBDE) CEO David Chin is pleased to announce today that the company will file a Letter of Intent for Grant Funding...
U.S. BioDefense Signs Agreement with NYSE Listed $4 Billion Biomedical Company
08 févr. 2005 11h07 HE
|
U.S. BioDefense
CITY OF INDUSTRY, Calif., Feb. 8, 2005 (PRIMEZONE) -- U.S. BioDefense (OTCBB:UBDE) is pleased to announce today that it has signed a secrecy agreement with the office of technology transfer at a NYSE...
U.S. BioDefense to Advertise on CNBC Next Week to Build Awareness of its California Stem Cell Technology Transfer Initiative
04 févr. 2005 09h00 HE
|
U.S. BioDefense
CITY OF INDUSTRY, Calif., Feb. 4, 2005 (PRIMEZONE) -- U.S. BioDefense, Inc. (OTCBB:UBDE), a Department of Defense central contractor that researches, develops, and commercializes leading-edge...
U.S. BioDefense Now Trading Under Stock Symbol UBDE
03 févr. 2005 10h20 HE
|
U.S. BioDefense
CITY OF INDUSTRY, Calif., Feb. 3, 2005 (PRIMEZONE) -- U.S. BioDefense, Inc. (OTCBB:UBDE), a Department of Defense central contractor that researches, develops, and commercializes leading-edge...
U.S. BioDefense Forward Stock Split Effective on Market Open Tomorrow Under New Stock Symbol UBDE
02 févr. 2005 14h51 HE
|
U.S. BioDefense
CITY OF INDUSTRY, Calif., Feb. 2, 2005 (PRIMEZONE) -- U.S. BioDefense, Inc. (OTCBB:UBDF) is pleased to announce today that it has been informed by the NASD that its three for one forward stock split...
U.S. BioDefense, Inc. Publishes White Paper: 'Collaborative Stem Cell Technology Commercialization Opportunities in California'
01 févr. 2005 15h44 HE
|
U.S. BioDefense
CITY OF INDUSTRY, Calif., Feb. 1, 2005 (PRIMEZONE) -- U.S. BioDefense, Inc. (OTCBB:UBDF) is pleased to announce today that it has released its White Paper at usbiodefense.com entitled "Collaborative...
U.S. BioDefense Extends Forward Stock Split Effective Date and Identifies New $4.5 Million National Institutes of Health SBIR Grant
01 févr. 2005 11h34 HE
|
U.S. BioDefense
CITY OF INDUSTRY, Calif., Feb. 1, 2005 (PRIMEZONE) -- U.S. BioDefense, Inc. (OTCBB:UBDF) CEO David Chin is pleased to announce that the company's forward stock split is on track, but has been briefly...
U.S. BioDefense, Inc. Applies for International Society for Stem Cell Research Membership
28 janv. 2005 08h45 HE
|
U.S. BioDefense
CITY OF INDUSTRY, Calif., Jan. 28, 2005 (PRIMEZONE) -- U.S. BioDefense, Inc. (OTCBB:UBDF) CEO David Chin is pleased to announce today that the company has submitted its application for membership in...